(2S,4S)-4-(tert-butoxy)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid, 95.0%, 250mg

(S)-1-(3-Methylbenzyl)pyrrolidin-3-aminedihydrochloride, 95.0%, 1g

3-(Hexylamino)propionitrile, 99.0%, 25g

2,2,2-Trifluoro-1-(4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazin-1-yl)ethan-1-one, 98%, 250mg

tert-Butyl 4-(4-(methoxycarbonyl)benzyl)piperidine-1-carboxylate, 98%, 1g

N-(3-methyl-5-nitrobenzyl)cyclopropanamine, 98%, 250mg

3-Butynyl p-toluenesulphonate, 98.0%, 5g

(S)-tert-butyl 2-(5-(4-chlorophenyl)-6,7-dimethyl-2-oxo-2,3-dihydro-1H-thieno[2,3-e][1,4]diazepin-3-yl)acetate, 98%, 250mg

6-Fluorochroman-4-amine, 95.0%, 5g

3-phenyl-4H-1,2,4-triazole, 95.0%, 1g

4-Bromopyridine, 98%, 25g

5-FLUORO-1H-INDAZOLE-3-CARBOXYLIC ACID, 95%, 10g

(+/-)-camphor, min. 95%, 500 g, plastic packaging.